Google
SNSE — SENSEI BIOTHERAPEUTICS INC (Healthcare >> Biotechnology)
SNSE FAQ
What is SNSE's ROE?
SENSEI BIOTHERAPEUTICS INC reports a Return on Equity (ROE) of -96.48%.
What is SNSE's dividend yield?
SENSEI BIOTHERAPEUTICS INC offers a dividend yield of 0.00%.
What is SNSE's Deepscope Quality Score?
Deepscope rates SNSE's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SNSE?
Deepscope's AI Timing Score for SNSE is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SNSE belong to?
SENSEI BIOTHERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 14.65
Price
-1.95
(-11.75%)
Day Change
|
|
|---|
SNSE, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 77 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 14.65 |
| PBV / Sector |
0.12 / 4.63
GREAT
|
| Earning Per Share | -121.31 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
0.71 M
GREAT
|
| Average 1W Daily Value |
0.86 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
68% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:09:21 |
| Symbol | SNSE |
| Name | SENSEI BIOTHERAPEUTICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 1.34 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 22.28 / 8,857.28 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1405 Research Boulevard, Rockville, MD, United States, 20850
Phone: 240 243 8000
Website: https://www.senseibio.com
Sector: Healthcare >> Biotechnology
Description: Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
